Mesenchymal stem cells support proliferation and terminal differentiation of B cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1526-1537

  Ji, Yue Ru ^a   Yang, Zhou Xin ^a   Han, Zhi Bo ^a,b   Meng, Lei ^a,b   Liang, Lu ^c   Feng, Xiao Ming ^a   Yang, Shao Guang ^a   Chi, Ying ^a   Chen, Dan Dan ^a   Wang, You Wei ^a,c   Han, Zhong Chao ^a,b,c  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b TEDA   (China)

^c Amcellgene Co Ltd   (China)

Author keywords

B cells; IL 6; Mesenchymal stem cells; PGE2

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; PROSTAGLANDIN E2;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL CONTACT; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

MUS;

EID: 84870738365     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343340     Document Type: Article

References (48)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403.
2. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228. (Pubitemid 32295155)
3. Bieback K, Kern S, Kluter H, Eichler H: Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625-634. (Pubitemid 39014578)
4. In't Anker PS, Scherjon SA, Kleijburg-Van der Keur C, De Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338-1345. (Pubitemid 39636409)
5. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006;91:1017-1026.
6. In 't Anker PS, Scherjon SA, Kleijburg-Van der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE, Kanhai HH: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003;102:1548-1549. (Pubitemid 36988070)
7. In 't Anker PS, Noort WA, Scherjon SA, Kleijburg-Van der Keur C, Kruisselbrink AB, Van Bezooijen RL, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE: Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88:845-852. (Pubitemid 37128084)
8. Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-3506. (Pubitemid 350159613)
9. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822. (Pubitemid 40223708)
10. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing t-cell anergy. Blood 2005;106:1755-1761. (Pubitemid 41208591)
11. Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, Cho CS: Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008;153:269-276.
12. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S: Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009;27:1421-1432.
13. Jones BJ, McTaggart SJ: Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 2008;36:733-741. (Pubitemid 351636190)
14. + monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. Exp Cell Res 2010;316:2414-2423.
15. Sun J, Han ZB, Liao W, Yang SG, Yang Z, Yu J, Meng L, Wu R, Han ZC: Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding cd4+cd25+ forkhead boxp3 (foxp3) + regulatory t cells and balancing anti-and pro-inflammatory factors. Cell Physiol Biochem 2011;27:587-596.
16. Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Zhu D, Bayard F, Han ZC: Human umbilical cord mesenchymal stem cells huc-mscs exert immunosuppressive activities through a pge (2)-dependent mechanism. Clin Immunol 2010;135:448-458.
17. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D: Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collageninduced arthritis. Arthritis Rheum 2005;52:1595-1603. (Pubitemid 40663952)
18. Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R: Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes 2010;59:3139-3147.
19. Zheng ZH, Li XY, Ding J, Jia JF, Zhu P: Allogeneic mesenchymal stem cell and mesenchymal stem celldifferentiated chondrocyte suppress the responses of type ii collagen-reactive t cells in rheumatoid arthritis. Rheumatology (Oxford) 2008;47:22-30. (Pubitemid 350286256)
20. Roord ST, De Jager W, Boon L, Wulffraat N, Martens A, Prakken B, Van Wijk F: Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through cd4+cd25+foxp3+ regulatory t cells. Blood 2008;111:5233-5241.
21. Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, Ruzek M, Tubo R, Kaplan J, Lodie T: Allogeneic mesenchymal stem cells do not protect nzbxnzw f1 mice from developing lupus disease. Clin Exp Immunol 2010;161:176-186.
22. Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, Martini A: Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of b cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008;26:562-569. (Pubitemid 351413617)
23. Dorner T, Jacobi AM, Lipsky PE: B cells in autoimmunity. Arthritis Res Ther 2009;11:247.
24. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U: Mice deficient in nuclear factor (nf)-kappa b/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 1998;187:147-159. (Pubitemid 28060431)
25. Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L: Mesenchymal stromal cells use pge2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, wharton's jelly and bone marrow sources. Cell Immunol 2010;264:171-179.
26. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM: Human bone marrow stromal cells suppress t-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843. (Pubitemid 34534559)
27. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D: Human bone marrow stromal cells inhibit allogeneic t-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621. (Pubitemid 38745993)
28. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K: Nitric oxide plays a critical role in suppression of t-cell proliferation by mesenchymal stem cells. Blood 2007;109:228-234. (Pubitemid 46053063)
29. Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN: Lung resident mesenchymal stem cells isolated from human lung allografts inhibit t cell proliferation via a soluble mediator. J Immunol 2008;181:4389-4396.
30. Ryan EP, Malboeuf CM, Bernard M, Rose RC, Phipps RP: Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J Immunol 2006;177:7811-7819. (Pubitemid 44846297)
31. Roper RL, Brown DM, Phipps RP: Prostaglandin e2 promotes b lymphocyte ig isotype switching to ige. J Immunol 1995;154:162-170.
32. Roper RL, Conrad DH, Brown DM, Warner GL, Phipps RP: Prostaglandin e2 promotes il-4-induced ige and igg1 synthesis. J Immunol 1990;145:2644-2651. (Pubitemid 20374591)
33. Roper RL, Graf B, Phipps RP: Prostaglandin e2 and camp promote b lymphocyte class switching to igg1. Immunol Lett 2002;84:191-198. (Pubitemid 35292378)
34. Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y: Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin e2. Tissue Eng 2007;13:1185-1195. (Pubitemid 46986719)
35. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L: Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2, 3-dioxygenase and prostaglandin e2. Blood 2008;111:1327-1333. (Pubitemid 351213419)
36. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L: Mesenchymal stem cells (msc) inhibit monocytederived dendritic cell (dc) maturation and function by selectively interfering with the generation of immature dcs: Central role of msc-derived prostaglandin e2. Blood 2009;113:6576-6583.
37. Betz M, Fox BS: Prostaglandin e2 inhibits production of th1 lymphokines but not of th2 lymphokines. J Immunol 1991;146:108-113.
38. Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D: Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007;25:2025-2032. (Pubitemid 47258180)
39. Wang D, Ji YR, Chen K, Du WT, Yang ZX, Han ZB, Chi Y, Liang L, Bayard F, Han ZC: Il-6 production stimulated by cd14 monocytes-paracrined il-1beta does not contribute to the immunosuppressive activity of human umbilical cord mesenchymal stem cells. Cell Physiol Biochem 2012;29:551-560.
40. Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T: Isolation and characterization of b cell differentiation factor (bcdf) secreted from a human b lymphoblastoid cell line. J Immunol 1984;132:2948-2954. (Pubitemid 14105681)
41. Maeda K, Mehta H, Drevets DA, Coggeshall KM: Il-6 increases b-cell igg production in a feedforward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood; 115:4699-4706.
42. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A: Human mesenchymal stem cells modulate b-cell functions. Blood 2006;107:367-372. (Pubitemid 43053565)
43. Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S: Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated b-cell immunoglobulin production in vitro. Cell Biol Int 2008;32:384-393.
44. Comoli P, Ginevri F, Maccario R, Avanzini MA, Marconi M, Groff A, Cometa A, Cioni M, Porretti L, Barberi W, Frassoni F, Locatelli F: Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 2008;23:1196-1202. (Pubitemid 351767482)
45. Asari S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, Mullen Y: Mesenchymal stem cells suppress b-cell terminal differentiation. Exp Hematol 2009;37:604-615.
46. Che N, Li X, Zhou S, Liu R, Shi D, Lu L, Sun L: Umbilical cord mesenchymal stem cells suppress b-cell proliferation and differentiation. Cell Immunol 2012, 274:46-53.
47. Ryan JM, Barry F, Murphy JM, Mahon BP: Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007;149:353-363. (Pubitemid 47063057)
48. Maby-El Hajjami H, Ame-Thomas P, Pangault C, Tribut O, De Vos J, Jean R, Bescher N, Monvoisin C, Dulong J, Lamy T, Fest T, Tarte K: Functional alteration of the lymphoma stromal cell niche by the cytokine context: Role of indoleamine-2, 3 dioxygenase. Cancer Res 2009;69:3228-3237.